Dianthus Therapeutics
$90.24
9
+$0.9+1.01% Tuesday 20:00
Statistics
Day High
90.9
Day Low
87.93
52W High
95.39
52W Low
16.86
Volume
331,908
Avg. Volume
-
Mkt Cap
3.87B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6AugExpected
Expected EPS
-1.066943
Actual EPS
N/A
Financials
-1,362.77%Profit Margin
Unprofitable12.47MRevenue
-169.94MNet Income
Analyst Ratings
124Average Price Target
The highest estimate is 200.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow DNTH. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Show more...
CEO
Mr. Marino Garcia M.B.A.
Employees
78
Country
United States
ISIN
US2528281080
Listings
0 Comments
Share your thoughts
FAQ
What is Dianthus Therapeutics stock price today?▼
The current price of DNTH is $90.24 USD — it has increased by +1.01% in the past 24 hours. Watch Dianthus Therapeutics stock price performance more closely on the chart.
What is Dianthus Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dianthus Therapeutics stocks are traded under the ticker DNTH.
Is Dianthus Therapeutics stock price growing?▼
DNTH stock has risen by +8.07% compared to the previous week, the month change is a +5.54% rise, over the last year Dianthus Therapeutics has showed a +352.33% increase.
What is Dianthus Therapeutics market cap?▼
Today Dianthus Therapeutics has the market capitalization of 3.87B
When is the next Dianthus Therapeutics earnings date?▼
Dianthus Therapeutics is going to release the next earnings report on August 06, 2026.
What were Dianthus Therapeutics earnings last quarter?▼
DNTH earnings for the last quarter are -0.85 USD per share, whereas the estimation was -1.06 USD resulting in a +20.01% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dianthus Therapeutics revenue for the last year?▼
Dianthus Therapeutics revenue for the last year amounts to 12.47M USD.
What is Dianthus Therapeutics net income for the last year?▼
DNTH net income for the last year is -169.94M USD.
How many employees does Dianthus Therapeutics have?▼
As of May 06, 2026, the company has 78 employees.
In which sector is Dianthus Therapeutics located?▼
Dianthus Therapeutics operates in the Health & Wellness sector.
When did Dianthus Therapeutics complete a stock split?▼
The last stock split for Dianthus Therapeutics was on September 12, 2023 with a ratio of 1:16.
Where is Dianthus Therapeutics headquartered?▼
Dianthus Therapeutics is headquartered in New York, United States.